Current Neuro-Oncology
Volume
11 Number 6
30 June 2009
Home > Publications > Current Neuro-Oncology > Volume 11, Year 2009 > Number 6, 30 June
Chiewvit P, Danchaivijitr N, Sirivitmaitrie K, Chiewvit S,
Thephamongkhol K.
Does magnetic
resonance imaging give value-added than bone scintigraphy in the
detection of vertebral metastasis?
J
Med Assoc Thai. 2009 Jun;92(6):818-29. PMID:
19530588. Observational study. ˍ
El Khashab M, Gargan L, Margraf L, Koral K, Nejat F, Swift D,
Weprin B, Bowers DC.
Predictors of
tumor progression among children with gangliogliomas. Clinical
article.
J
Neurosurg Pediatr. 2009 Jun;3(6):461-6. doi:
10.3171/2009.2.PEDS0861. PMID:
19485728. Observational study. ˍ
Olufemi Adeleye A, Balogun JA.
Bilateral
deafness and blindness from a IVth ventricular medulloblastoma.
Br
J Neurosurg. 2009 Jun;23(3):315-7. doi:
10.1080/02688690802512858. PMID:
19533466. Case report. ˍ
Benesch M, Moser A, Sovinz P, Lackner H, Schwinger W, Eder H,
Urban C.
Medulloblastoma in a child
with down syndrome: long-term remission with multimodality
treatment.
Pediatr
Blood Cancer. 2009 June 1;53(6):1150-1. doi:
10.1002/pbc.22109. PMID:
19489060. Case report. ˍ
Li Z, Bao S, Wu Q, Wang H, Eyler C,
Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, Hjelmeland
AB, Rich JN.
Hypoxia-inducible
factors regulate tumorigenic capacity of glioma stem cells.
Cancer
Cell. 2009 Jun
2;15(6):501-13. doi:
10.1016/j.ccr.2009.03.018. PMID:
19477429. Laboratory investigation. ˍ
Neyns B, Sadones J, Joosens E, Bouttens F, Verbeke L, Baurain JF,
D'Hondt L, Strauven T, Chaskis C, In't Veld P, Michotte A, De
Greve J.
Stratified phase II trial of
cetuximab in patients with recurrent high-grade glioma.
Ann
Oncol. 2009 2009 Jun 2;20(9):1596-1603. doi:
10.1093/annonc/mdp032. PMID:
19491283. Interventional study. ˍ
Reimers TS, Mortensen EL, Nysom K, Schmiegelow K.
Health-related
quality of life in long-term survivors of childhood brain
tumors.
Pediatr
Blood Cancer. 2009 Jun 4;53(6):1086-91. doi:
10.1002/pbc.22122. PMID:
19499581. Observational study. ˍ
Fu J, Liu ZG, Liu XM, Chen FR, Shi HL, Pangjesse CS, Ng HK, Chen
ZP.
Glioblastoma stem cells resistant
to temozolomide-induced autophagy.
Chin
Med J (Engl). 2009 Jun 5;122(11):1255-9. doi:
10.3760/cma.j.issn.0366-6999.2009.11.004. PMID:
19567133. Laboratory investigation. ˍ
*Gao S, Yang XJ, Zhang WG, Ji YW, Pan Q.
Mechanism
of thalidomide to enhance cytotoxicity of temozolomide in U251-MG
glioma cells in vitro.
Chin
Med J (Engl). 2009 Jun 5;122(11):1260-6. doi:
10.3760/cma.j.issn.0366-6999.2009.11.005. PMID:
19567134. Laboratory investigation. ˍ
Li SW, Qiu XG, Chen BS, Zhang W, Ren H, Wang ZC, Jiang
T.
Prognostic factors influencing
clinical outcomes of glioblastoma multiforme.
Chin
Med J (Engl). 2009 Jun 5;122(11):1245-9. doi:
10.3760/cma.j.issn.0366-6999.2009.11.002. PMID:
19567131. Observational study. ˍ
Thiessen B, Stewart C, Tsao M, Kamel-Reid S, Schaiquevich P, Mason
W, Easaw J, Belanger K, Forsyth P, McIntosh L, Eisenhauer E.
A
phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma
multiforme: clinical outcomes, pharmacokinetics and molecular
correlation.
Cancer
Chemother Pharmacol. 2009 Jun 5;65(2):353-61. doi:
10.1007/s00280-009-1041-6. PMID:
19499221. Interventional study. ˍ
Zhang W, Qiu XG, Chen BS, Li SW, Cui Y, Ren H, Jiang
T.
Antiangiogenic therapy with
bevacizumab in recurrent malignant gliomas: analysis of the
response and core pathway aberrations.
Chin
Med J (Engl). 2009 Jun 5;122(11):1250-4. doi:
10.3760/cma.j.issn.0366-6999.2009.11.003. PMID:
19567132. Observational study. ˍ
Baruchel S, Sharp JR, Bartels U, Hukin J, Odame I, Portwine C,
Strother D, Fryer C, Halton J, Egorin MJ, Reis RM, Martinho O,
Stempak D, Hawkins C, Gammon J, Bouffet E.
A
Canadian paediatric brain tumour consortium (CPBTC) phase II
molecularly targeted study of imatinib in recurrent and refractory
paediatric central nervous system tumours.
Eur
J Cancer. 2009 Jun 6;45(13):2352-9. doi:
10.1016/j.ejca.2009.05.008. PMID:
19505817. Interventional study. ˍ
Pellegatta S, Finocchiaro G.
Dendritic
cell vaccines for cancer stem cells.
Methods
Mol Biol. 2009 Jun 7;568:233-47. doi:
10.1007/978-1-59745-280-9_15. PMID:
19582431. Laboratory investigation protocol. ˍ
Clarke JL, Iwamoto FM, Sul J, Panageas K, Lassman AB, DeAngelis
LM, Hormigo A, Nolan CP, Gavrilovic I, Karimi S, Abrey
LE.
Randomized phase II trial of
chemoradiotherapy followed by either dose-dense or metronomic
temozolomide for newly diagnosed glioblastoma.
J
Clin Oncol. 2009 Jun 8;27(23):3861-7. doi:
10.1200/JCO.2008.20.7944. PMID:
19506159. Interventional study. ˍ
Affronti ML, Heery CR, Herndon JE 2nd, Rich JN, Reardon DA,
Desjardins A, Vredenburgh JJ, Friedman AH, Bigner DD, Friedman
HS.
Overall survival of newly diagnosed
glioblastoma patients receiving carmustine wafers followed by
radiation and concurrent temozolomide plus rotational multiagent
chemotherapy.
Cancer.
2009 June 9;115(15):3501-11. doi:
10.1002/cncr.24398. PMID:
19514083. Observational study. ˍ
Brandes AA, Franceschi E, Tosoni A, Benevento F, Scopece L,
Mazzocchi V, Bacci A, Agati R, Calbucci F, Ermani M.
Temozolomide
concomitant and adjuvant to radiotherapy in elderly patients with
glioblastoma: correlation with MGMT promoter methylation
status.
Cancer.
2009 June 9;115(15):3512-8. doi:
10.1002/cncr.24406. PMID:
19514084. Observational study. ˍ
Raza S, Donach M.
Bevacizumab in adult
malignant brainstem gliomas.
J
Neurooncol. 2009 June 9;95(2):299-300. doi:
10.1007/s11060-009-9933-1. PMID:
19506812. Letter to the editor. ˍ
Related
article:
Torcuator R, Zuniga R, Loutfi R, Mikkelsen
T.
Bevacizumab
and irinotecan treatment for progressive diffuse brainstem glioma:
case report.
J
Neurooncol.
2009 Jan 13;93(3):409-12. doi:
10.1007/s11060-008-9782-3. PMID:
19139822. Case report. ˍ
*D'Urso OF, D'Urso PI, Marsigliante S, Storelli C, Luzi G,
Gianfreda CD, Montinaro A, Distante A, Ciappetta P.
Correlative
analysis of gene expression profile and prognosis in patients with
gliomatosis cerebri.
Cancer.
2009 June 10;115(16):3749-57. doi:
10.1002/cncr.24435. PMID:
19517475. Laboratory investigation.
ˍ
Rachinger W, Grau S, Holtmannspötter M, Herms J, Tonn JC,
Kreth FW.
Serial stereotactic biopsy of
brainstem lesions in adults improves diagnostic accuracy compared
with MRI only.
J
Neurol Neurosurg Psychiatry. 2009 Jun 10;80(10):1134-9.
doi:
10.1136/jnnp.2009.174250. PMID:
19520698. Observational study. ˍ
Frange P, Alapetite C, Gaboriaud G, Bours D, Zucker JM, Zerah M,
Brisse H, Chevignard M, Mosseri V, Bouffet E, Doz F.
From
childhood to adulthood: long-term outcome of medulloblastoma
patients. The Institut Curie experience (1980-2000).
J
Neurooncol. 2009 Jun 12;95(2):271-279. doi:
10.1007/s11060-009-9927-z. PMID:
19521664. Observational study. ˍ
Ward E, Hopkins M, Arbuckle L, Williams N, Forsythe L, Bujkiewicz
S, Pizer B, Estlin E, Picton S.
Nutritional
problems in children treated for medulloblastoma: implications for
enteral nutrition support.
Pediatr
Blood Cancer. 2009 June 15;53(4):570-5. doi:
10.1002/pbc.22092. PMID:
19530236. Observational study. ˍ
Corn BW, Wang M, Fox S, Michalski J, Purdy J, Simpson J, Kresl J,
Curran WJ Jr, Diaz A, Mehta M, Movsas B.
Health
related quality of life and cognitive status in patients with
glioblastoma multiforme receiving escalating doses of conformal
three dimensional radiation on RTOG 98-03.
J
Neurooncol. 2009 Jun 16;95(2):247-257. doi:
10.1007/s11060-009-9923-3. PMID:
19533025. Interventional study. ˍ
Kuttesch JF Jr, Krailo MD, Madden T, Johansen M, Bleyer A;
Children's Oncology Group.
Phase II
evaluation of intravenous vinorelbine (Navelbine) in recurrent or
refractory pediatric malignancies: a Children's Oncology Group
study.
Pediatr
Blood Cancer. 2009 June 16;53(4):590-3. doi:
10.1002/pbc.22133. PMID:
19533657. Interventional study. ˍ
Moreno L, Bautista FJ, Zacharoulis S.
Outcome
of teenagers and young adults with ependymoma: the Royal Marsden
experience.
Childs
Nerv Syst. 2009 Jun 16;25(9):1047-52. doi:
10.1007/s00381-009-0920-9. PMID:
19533154. Observational study. ˍ
Sharma A, Gupta D, Mohanti BK, Thulkar S, Dwary A, Goyal S,
Muzumder S, Das P.
Non-Hodgkin lymphoma
following temozolomide.
Pediatr
Blood Cancer. 2009 June 16;53(4):661-2. doi:
10.1002/pbc.22090. PMID:
19533661. Case report. ˍ
Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W,
Hudson MM, Donaldson SS, King AA, Stovall M, Krull KR, Robison LL,
Packer RJ.
Long-term outcomes among
adult survivors of childhood central nervous system malignancies
in the Childhood Cancer Survivor Study.
J
Natl Cancer Inst. 2009 Jun 17;101(13):946-58. doi:
10.1093/jnci/djp148. PMID:
19535780. Observational study. ˍ
Ellis JA, Waziri A, Balmaceda C, Canoll P, Bruce JN, Sisti
MB.
Rapid recurrence and malignant
transformation of pilocytic astrocytoma in adult patients.
J
Neurooncol. 2009 Jun 17;95(3):377-382. doi:
10.1007/s11060-009-9935-z. PMID:
19533024. Observational study. ˍ
Forinder U, Lindahl Norberg A.
"Now
we have to cope with the rest of our lives". Existential
issues related to parenting a child surviving a brain
tumour.
Support
Care Cancer. 2009 Jun 17;18(5):543-51. doi:
10.1007/s00520-009-0678-3. PMID:
19669170. Observational study. ˍ
Murat A, Migliavacca E, Hussain SF, Heimberger AB, Desbaillets I,
Hamou MF, Rüegg C, Stupp R, Delorenzi M, Hegi ME.
Modulation
of angiogenic and inflammatory response in glioblastoma by
hypoxia.
PLoS
One. 2009 Jun 17;4(6):e5947. doi:
10.1371/journal.pone.0005947. PMID:
19536297. Laboratory investigation.
ˍ
Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ,
Friedman AH, Sampson JH, McLendon RE, Herndon JE 2nd, Friedman
HS.
Phase II trial of temozolomide
(TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed
glioblastoma multiforme before radiotherapy.
J
Neurooncol. 2009 Jun 17;95(3):393-400. doi:
10.1007/s11060-009-9937-x. PMID:
19533023. Interventional study. ˍ
Schomas DA, Laack NN, Brown PD.
Low-grade
gliomas in older patients: long-term follow-up from Mayo
Clinic.
Cancer.
2009 June 17;115(17):3969-78. doi:
10.1002/cncr.24444. PMID:
19536875. Observational study. ˍ
Gauden AJ, Hunn A, Erasmus A, Waites P, Dubey A, Gauden
SJ.
Combined modality treatment of
newly diagnosed glioblastoma multiforme in a regional
neurosurgical centre.
J
Clin Neurosci. 2009 Jun 18;16(9):1174-9. doi:
10.1016/j.jocn.2008.12.008. PMID:
19540125. Observational study. ˍ
Korshunov A, Meyer J, Capper D, Christians A, Remke M, Witt H,
Pfister S, von Deimling A, Hartmann C.
Combined
molecular analysis of BRAF and IDH1 distinguishes pilocytic
astrocytoma from diffuse astrocytoma.
Acta
Neuropathol. 2009 Jun 19;118(3):401-5. doi:
10.1007/s00401-009-0550-z. PMID:
19543740. Laboratory investigation.
ˍ
Budrukkar A, Jalali R, Dutta D, Sarin R, Devlekar R, Parab S,
Kakde A.
Prospective assessment of
quality of life in adult patients with primary brain tumors in
routine neurooncology practice.
J
Neurooncol. 2009 Jun 23;95(3):413-419. doi:
10.1007/s11060-009-9939-8. PMID:
19548070. Observational study. ˍ
Mehrotra N, Shamji MF, Vassilyadi M, Ventureyra EC.
Intracranial
tumors in first year of life: the CHEO experience.
Childs
Nerv Syst. 2009 Jun 24;25(12):1563-9. doi:
10.1007/s00381-009-0936-1. PMID:
19551387. Observational study. ˍ
Behdad A, Perry A.
Central nervous
system primitive neuroectodermal tumors: a
clinicopathologic and genetic study
of 33 cases.
Brain
Pathol. 2009 Jun 25;20(2):441-50. doi:
10.1111/j.1750-3639.2009.00314.x. PMID:
19725831. Observational study. ˍ
Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A,
Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C,
Unterberg A, Jeuken JW, Wesseling P, Reifenberger G, von Deimling
A.
Type and frequency of IDH1 and IDH2
mutations are related to astrocytic and oligodendroglial
differentiation and age: a study of 1,010 diffuse gliomas.
Acta
Neuropathol. 2009 Jun 25;118(4):469-74. doi:
10.1007/s00401-009-0561-9. PMID:
19554337. Laboratory investigation.
ˍ
*Hottinger AF, Yoon H, DeAngelis LM, Abrey LE.
Neurological
outcome of long-term glioblastoma survivors.
J
Neurooncol. 2009 Jun 26;95(3):301-305. doi:
10.1007/s11060-009-9946-9. PMID:
19557499. Observational study. ˍ
Shaffer R, Nichol AM, Vollans E, Fong M, Nakano S, Moiseenko V,
Schmuland M, Ma R, McKenzie M, Otto K.
A
comparison of volumetric modulated arc therapy and conventional
intensity-modulated radiotherapy for frontal and temporal
high-grade gliomas.
Int
J Radiat Oncol Biol Phys. 2009 Jun 27;76(4):1177-84.
doi:
10.1016/j.ijrobp.2009.03.013. PMID:
19560880. Observational study. ˍ
Reardon DA, Desjardins A, Vredenburgh JJ, Gururangan S, Friedman
AH, Herndon JE 2nd, Marcello J, Norfleet JA, McLendon RE, Sampson
JH, Friedman HS.
Phase 2 trial of
erlotinib plus sirolimus in adults with recurrent glioblastoma.
J
Neurooncol. 2010 Jun 28;96(2):219-30. doi:
10.1007/s11060-009-9950-0. PMID:
19562254. Interventional study. ˍ
Jang SY, Kong MH, Song KY, Frazee JG.
Intracranial
Metastases of Cervical Intramedullary Low-Grade Astrocytoma
without Malignant Transformation in Adult.
J
Korean Neurosurg Soc. 2009 Jun 30;45(6):381-5. doi:
10.3340/jkns.2009.45.6.381. PMID:
19609424. Case report. ˍ